fashion -WSS

fashion

author：explore 2025-08-23 08:57:17 - browse：56

research funding, medical devices — APStock

WASHINGTON — A federal district judge on Monday granted the Biden administration’s request to dismiss a lawsuit challenging Medicare’s new drug price negotiation program from the drug industry lobbying organization PhRMA.

The move is an early but positive sign for the Biden administration in a legal fight that could stretch for years, as a host of major drugmakers, including Merck, Bristol Myers Squibb, and Johnson & Johnson, have also filed lawsuits over the constitutionality of Medicare’s new powers. The first round of drug negotiations is ongoing, and a judge heard oral arguments in a challenge brought by AstraZeneca just last month.

Newsletters

Sign up for D.C. Diagnosis

Washington never stops. Cut through the noise with our essential updates on health care politics and policy

Please enter a valid email address. Privacy Policy

The National Infusion Center Association and the Global Colon Cancer Association are also plaintiffs in PhRMA’s lawsuit. The judge dismissed the National Infusion Center Association from the case because it did not have subject matter jurisdiction to bring the lawsuit. And because NICA was the only party to the lawsuit that resides in Texas, the judge tossed out the case in its entirety.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

knowledge

WSS

AMAs digital advisors table RPM coding reform proposal, again

Sanofi seeks simpler, safer CRISPR sickle cell cure

ACIP vaccine advisory panel sees its vacancies filled

Biden tests positive for Covid

Custom gene therapy hints at new path for rare disease treatments

Medicare has a new plan to address drug shortages

explore

fashion

Sign up for D.C. Diagnosis

knowledge

Medical leaders decry Supreme Court decision on affirmative action

Biden tests positive for Covid

Anesthesiologist group: stop taking Ozempic before surgery

FDA approves RSV monoclonal antibody for infants, toddlers

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Why don't Americans have at

Duchenne breakthrough therapy leaves behind pioneering families

Listen: Wegovy in the brain & pivotal Alzheimer's data

Guidelines to prevent youth baseball injuries need more muscle

Tome Biosciences co

hotspot

At Orexo, a ‘turning point’ for everything but digital health

Sanofi seeks simpler, safer CRISPR sickle cell cure

Resistance to opioid

Doctors find melanoma drugs effective against rare brain cancer

Ebola vaccine can save some who are already sick, per new study

STAT Virtual Event: The State of Biosimilars: What to Watch

knowledge

hotspot

knowledge

Wikipedia